Investing.com - Novocure Ltd reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Novocure Ltd announced earnings per share of $-0.25 on revenue of $130.99. Analysts polled by Investing.com EPS of $-0.26 on revenue of $132.42M.
Novocure Ltd 's are down 4% and is trading at $67.02 , still down 39.77% from its 52 week high of $116.56 set on Monday, November 15, 2021.
Novocure Ltd shares lost 4.53% to trade at $67.02 in pre-market trade the report.
Novocure Ltd follows other major Healthcare sector earnings this month
Novocure Ltd's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar